课题基金 / 基金详情

Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections

Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
病毒感染中人类细胞毒性 CD4 T 细胞 (CD4-CTL) 的生物学
批准号:
10169569
负责人:
Pandurangan Vijayanand
金额:
$59.68万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-05-26 至 2021-02-28

项目摘要

项目成果

Pandurangan Vijayanand的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Overall Component COVID19 is a severe ongoing pandemic. Our understanding of the immune response to this disease is lacking, which impairs both the development of proper therapeutics and a vaccine. Vaccines are one of the most cost effective and extraordinarily successful medical interventions. Most of those vaccines depend on CD4 T+ cells and their help to B cells. We have developed multiple new techniques to study human CD4+ T cells over the past several years, which have have been implementing in our LJI CCHI. The supplement proposed here will facilitate rapid and vigorous pursuit of an understanding of the T cell responses to SARS-CoV2 in humans, which may help in the development of treatments and vaccines for COVID19.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
  • 批准号:
    10580761
  • 项目类别:
  • 资助金额:
    $69.81万
  • 财政年份:
    2019
  • 负责人:
    Pandurangan Vijayanand
  • 依托单位:
Biology of human cytotoxic CD4 T cells (CD4-CTLs) in viral infections
  • 批准号:
    10578441
  • 项目类别:
  • 资助金额:
    $45.24万
  • 财政年份:
    2019
  • 负责人:
    Pandurangan Vijayanand
  • 依托单位:
Epitope validation of fungal allergens in severe asthma
  • 批准号:
    10321625
  • 项目类别:
  • 资助金额:
    $34.95万
  • 财政年份:
    2018
  • 负责人:
    Pandurangan Vijayanand
  • 依托单位:
Clinical Core
  • 批准号:
    10083708
  • 项目类别:
  • 资助金额:
    $1.47万
  • 财政年份:
    2018
  • 负责人:
    Pandurangan Vijayanand
  • 依托单位:
国内基金
海外基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
  • 批准号:
    2022J011295
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    王亚伟
  • 依托单位:
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究